CIK 0001574235 · Non-accelerated filer<br>Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461821392
- Phone
- (888) 355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-03 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2023-01-26 | Wasilewski Margaret Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +11,400 | 11,400 | ||
| 2023-01-26 | Siegert Michelle Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2023-01-26 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +34,900 | 34,900 | ||
| 2023-01-26 | Cabell Christopher Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2023-01-26 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +2,436 | 2,436 | ||
| 2023-01-26 | Bazemore Todd Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2023-01-26 | Varadan Anand Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2023-01-26 | Batycky Richard P. Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2022-03-01 | Wasilewski Margaret Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +21,060 | 21,060 | ||
| 2022-01-27 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +36,833 | 36,833 | ||
| 2022-01-27 | Batycky Richard P. Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2022-01-27 | Cabell Christopher Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2022-01-27 | Bazemore Todd Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2022-01-27 | Varadan Anand Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2022-01-27 | Siegert Michelle Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +184,300 | 184,300 | ||
| 2022-01-27 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2021-07-26 | Varadan Anand Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-01-28 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-01-28 | Cabell Christopher Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 1 of 8 · 154 trades